Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection

被引：8
|
作者：
Beckebaum, S
Cicinnati, VR
Karliova, M
Dirsch, O
Erim, Y
Frilling, A
Malago, M
Broelsch, CE
Treichel, U
Gerken, G
机构：
[1] Univ Hosp Essen, Dept Gen Surg & Transplantat, D-45122 Essen, Germany
[2] Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany
[3] Univ Hosp Essen, Dept Pathol, D-45122 Essen, Germany
[4] Univ Hosp Essen, Dept Psychotherapy & Psychosomat, D-45122 Essen, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 2003年 / 35卷 / 06期
关键词：
D O I：
10.1016/S0041-1345(03)00681-X
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2080 / 2081
页数：2
相关论文
共 50 条
  • [1] Combination therapy with interferon alpha-2b and ribavirin in naive patients with chronic hepatitis C
    Juszczyk, J
    Bolewska, B
    Cianciara, J
    Jablonska, J
    Zaborowski, P
    Niedzialek, D
    Gladysz, A
    Piszko, P
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 199 - 199
  • [2] Ribavirin in combination with alpha-2b interferon for the treatment of chronic hepatitis C
    Hillon, P
    [J]. PRESSE MEDICALE, 2001, 30 (07): : 335 - 336
  • [3] Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection
    Takayama, Tetsuro
    Ebinuma, Hirotoshi
    Tada, Shinichiro
    Yamagishi, Yoshiyuki
    Wakabayashi, Kanji
    Ojiro, Keisuke
    Kanai, Takanori
    Saito, Hidetsugu
    Hibi, Toshifumi
    [J]. PLOS ONE, 2011, 6 (12):
  • [4] Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation
    Castedal, M
    Siewert-Delle, A
    Olausson, M
    Friman, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 820 - 821
  • [5] Combination pegylated interferon alpha-2b and ribavirin in transplant patients with recurrent hepatitis C infection: A preliminary report.
    Vargas, HE
    Rosati, MJ
    Douglas, DD
    Harrison, ME
    Mulligan, DC
    Moss, AA
    Rakela, J
    Balan, V
    [J]. HEPATOLOGY, 2001, 34 (04) : 407A - 407A
  • [6] Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection
    Sulkowski, MS
    Wasserman, R
    Brooks, L
    Ball, L
    Gish, R
    [J]. JOURNAL OF VIRAL HEPATITIS, 2004, 11 (03) : 243 - 250
  • [7] Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis C
    Younossi, ZM
    Mullen, KD
    Hodnick, S
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Gramlich, T
    Liebermann, BY
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (05) : 427 - 430
  • [8] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Mukherjee, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03): : 727 - 727
  • [9] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Jacobson, IM
    Ahmed, F
    Russo, MW
    Lebovics, E
    Dieterich, DI
    Esposito, SP
    Bach, N
    Klion, F
    Tobias, H
    Antignano, L
    Brown, RS
    Gabbaizadeh, D
    Geders, J
    Levendoglu, H
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1700 - 1705
  • [10] Ribavirin and interferon alpha-2b combination treatment of chronic hepatitis C is effective in patients with clotting disorders
    Fried, R
    Meili, E
    Peter, K
    Hartmann, S
    Tsakiris, D
    Egger, H
    Marbet, G
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A382 - A383
12345